The course of the HIV epidemic among intravenous drug users in Amsterdam, The Netherlands.
Author(s) -
H J van Haastrecht,
J A van den Hoek,
C Bardoux,
A Leentvaar-Kuypers,
R A Coutinho
Publication year - 1991
Publication title -
american journal of public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.284
H-Index - 264
eISSN - 1541-0048
pISSN - 0090-0036
DOI - 10.2105/ajph.81.1.59
Subject(s) - medicine , incidence (geometry) , seroprevalence , intravenous drug , human immunodeficiency virus (hiv) , cohort , demography , drug , epidemiology , virology , viral disease , immunology , antibody , pediatrics , pharmacology , serology , physics , sociology , optics
To determine if behavioral changes in intravenous drug users in Amsterdam have retarded the HIV (human immunodeficiency virus) epidemic in this group in recent years, we report that: HIV-antibody seroprevalence in annual samples of injectors has been constant over the years 1986-89; HIV-antibody incidence in a cohort of injectors appears to have decreased from 1986 to 1987 and stabilized after that until 1989; acute hepatitis B incidence in all drug users in Amsterdam declined rapidly between 1985-89. It is concluded that changes in drug use behavior so far appear to have resulted in a stabilization of the epidemic among injectors, at a level with a still disturbingly high incidence rate of 5-6 per 100 person-years.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom